Literature DB >> 22174376

Complex human glucocorticoid receptor dim mutations define glucocorticoid induced apoptotic resistance in bone cells.

Christine M Jewell1, Alyson B Scoltock, Brant L Hamel, Matthew R Yudt, John A Cidlowski.   

Abstract

A mutation in the D-loop of the second zinc finger of the DNA-binding domain of the human glucocorticoid receptor (hGR), A458T (GR(dim)), has been suggested to be essential for dimerization and DNA binding of the GR, and genetically altered GR(dim) mice survive, whereas murine GR knockout mice die. Interestingly, thymocytes isolated from the GR(dim) mice were reported to be resistant to glucocorticoid-induced apoptosis. To further evaluate the dim mutations in glucocorticoid-induced apoptosis, we stably expressed either the hGR(dim) (A458T) or the hGR(dim4) (A458T, R460D, D462C, and N454D) mutant receptors in human osteosarcoma (U-2 OS) cells that are devoid of hGR and unresponsive to glucocorticoids. We analyzed these cell lines by comparison with a stable expression hGRα U-2 OS cell line, which undergoes apoptosis after glucocorticoid treatment. Transient reporter gene assays with glucocorticoid response element-driven vectors revealed that the hGR(dim) mutation had diminished steroid responsiveness and cells carrying the hGR(dim4) mutation were unresponsive to steroid, whereas glucocorticoid-induced nuclear factor κB repression was unaffected by either mutation. Interestingly, both the hGR(dim) and hGR(dim4) receptors readily formed dimers as measured by immunoprecipitation. Examination of GR-mediated apoptosis showed that hGR(dim) cells were only partially resistant to apoptosis, whereas hGR(dim4) cells were completely resistant to glucocorticoid-induced cell death despite remaining sensitive to other apoptotic stimuli. Global gene expression analysis revealed that hGR(dim4) cells widely regulated gene expression but differentially regulated apoptotic mRNA when compared with cells expressing wild-type hGRα. These studies challenge conclusions drawn from previous studies of GR dim mutants.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22174376      PMCID: PMC3275167          DOI: 10.1210/me.2011-1116

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  44 in total

1.  CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism.

Authors:  L I McKay; J A Cidlowski
Journal:  Mol Endocrinol       Date:  2000-08

Review 2.  Structure of the glucocorticoid receptor, a flexible protein that can adapt to different ligands.

Authors:  Adriana S Veleiro; Lautaro D Alvarez; Silvina L Eduardo; Gerardo Burton
Journal:  ChemMedChem       Date:  2010-05-03       Impact factor: 3.466

3.  Molecular evidence for a link between the N363S glucocorticoid receptor polymorphism and altered gene expression.

Authors:  Christine M Jewell; John A Cidlowski
Journal:  J Clin Endocrinol Metab       Date:  2007-05-29       Impact factor: 5.958

4.  Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor.

Authors:  Nick Z Lu; Jennifer B Collins; Sherry F Grissom; John A Cidlowski
Journal:  Mol Cell Biol       Date:  2007-08-06       Impact factor: 4.272

5.  Mapping of glucocorticoid receptor DNA binding domain surfaces contributing to transrepression of NF-kappa B and induction of apoptosis.

Authors:  Y Tao; C Williams-Skipp; R I Scheinman
Journal:  J Biol Chem       Date:  2000-12-05       Impact factor: 5.157

6.  Point mutation in the mouse glucocorticoid receptor preventing DNA binding impairs spatial memory.

Authors:  M S Oitzl; H M Reichardt; M Joëls; E R de Kloet
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

7.  Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor.

Authors:  Raoul Frijters; Wilco Fleuren; Erik J M Toonen; Jan P Tuckermann; Holger M Reichardt; Hans van der Maaden; Andrea van Elsas; Marie-Jose van Lierop; Wim Dokter; Jacob de Vlieg; Wynand Alkema
Journal:  BMC Genomics       Date:  2010-06-05       Impact factor: 3.969

8.  Glucocorticoid receptor is required for skin barrier competence.

Authors:  Pilar Bayo; Ana Sanchis; Ana Bravo; Jose Luis Cascallana; Katrin Buder; Jan Tuckermann; Günther Schütz; Paloma Pérez
Journal:  Endocrinology       Date:  2007-11-26       Impact factor: 4.736

9.  DNA binding site sequence directs glucocorticoid receptor structure and activity.

Authors:  Sebastiaan H Meijsing; Miles A Pufall; Alex Y So; Darren L Bates; Lin Chen; Keith R Yamamoto
Journal:  Science       Date:  2009-04-17       Impact factor: 47.728

10.  The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin.

Authors:  J P Tuckermann; H M Reichardt; R Arribas; K H Richter; G Schütz; P Angel
Journal:  J Cell Biol       Date:  1999-12-27       Impact factor: 10.539

View more
  32 in total

Review 1.  Nuclear Receptor Function through Genomics: Lessons from the Glucocorticoid Receptor.

Authors:  Daniel M Cohen; David J Steger
Journal:  Trends Endocrinol Metab       Date:  2017-05-08       Impact factor: 12.015

Review 2.  Glucocorticoids and Reproduction: Traffic Control on the Road to Reproduction.

Authors:  Shannon Whirledge; John A Cidlowski
Journal:  Trends Endocrinol Metab       Date:  2017-03-06       Impact factor: 12.015

3.  Glucocorticoid Receptor Mutations and Hypersensitivity to Endogenous and Exogenous Glucocorticoids.

Authors:  Richard J Santen; Christine M Jewell; Wei Yue; Daniel F Heitjan; Hershel Raff; Kevin S Katen; John A Cidlowski
Journal:  J Clin Endocrinol Metab       Date:  2018-10-01       Impact factor: 5.958

4.  Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.

Authors:  Valentina Camozzi; Corrado Betterle; Anna Chiara Frigo; Veronica Zaccariotto; Martina Zaninotto; Erica De Caneva; Paola Lucato; Walter Gomiero; Silvia Garelli; Chiara Sabbadin; Monica Salvà; Miriam Dalla Costa; Marco Boscaro; Giovanni Luisetto
Journal:  Endocrine       Date:  2017-08-09       Impact factor: 3.633

5.  DNA binding triggers tetramerization of the glucocorticoid receptor in live cells.

Authors:  Diego M Presman; Sourav Ganguly; R Louis Schiltz; Thomas A Johnson; Tatiana S Karpova; Gordon L Hager
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-05       Impact factor: 11.205

6.  A hotspot in the glucocorticoid receptor DNA-binding domain susceptible to loss of function mutation.

Authors:  Jesus Banuelos; Soon Cheon Shin; Nick Z Lu
Journal:  Steroids       Date:  2015-02-09       Impact factor: 2.668

7.  HES1 is a master regulator of glucocorticoid receptor-dependent gene expression.

Authors:  Javier R Revollo; Robert H Oakley; Nick Z Lu; Mahita Kadmiel; Maheer Gandhavadi; John A Cidlowski
Journal:  Sci Signal       Date:  2013-12-03       Impact factor: 8.192

Review 8.  Glucocorticoid Signaling in Health and Disease: Insights From Tissue-Specific GR Knockout Mice.

Authors:  Shannon Whirledge; Donald B DeFranco
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

Review 9.  Glucocorticoid therapy and ocular hypertension.

Authors:  Adnan Dibas; Thomas Yorio
Journal:  Eur J Pharmacol       Date:  2016-07-05       Impact factor: 4.432

10.  Regulation of the CCL2 gene in pancreatic β-cells by IL-1β and glucocorticoids: role of MKP-1.

Authors:  Susan J Burke; Matthew R Goff; Barrett L Updegraff; Danhong Lu; Patricia L Brown; Steven C Minkin; John P Biggerstaff; Ling Zhao; Michael D Karlstad; J Jason Collier
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.